PRESS RELEASE published on 02/28/2024 at 10:00, 1 year 11 months ago Karl Lauterbach visits Biotest AG's plasma donation centre in Cologne and emphasises important contribution to patient care Prof Dr Karl Lauterbach visits Biotest AG's plasma donation centre in Cologne, emphasizing vital contribution to patient care. Plasma donation in Germany crucial for medical supply Germany Patient Care Biotest AG Karl Lauterbach Plasma Donation
BRIEF published on 02/28/2024 at 10:00, 1 year 11 months ago Visit of Karl Lauterbach to the plasma donation center of Biotest AG in Cologne Germany Biotest AG Karl Lauterbach Plasma Donation Medical Care
PRESS RELEASE published on 02/14/2024 at 08:30, 1 year 11 months ago Biotest successfully meets primary endpoint in phase III trial with Fibrinogen concentrate Biotest successfully meets primary endpoint in phase III trial with Fibrinogen concentrate. Study results confirm safety profile & effectiveness equal to standard care in reducing blood loss. Biotest aims to address global medical need with USD 800 million market potential Biotest AG Fibrinogen Concentrate Phase III Trial Study Results Medical Market Potential
PRESS RELEASE published on 11/28/2023 at 09:00, 2 years 2 months ago EQS-News: Biotest’s Trimodulin shows reduced mortality in patients with severe community-acquired pneumonia through rapid normalisation of inflammation
PRESS RELEASE published on 11/02/2023 at 08:00, 2 years 2 months ago Biotest increases EBIT to Euro 125.4 million in the first nine months of 2023
PRESS RELEASE published on 10/05/2023 at 16:55, 2 years 3 months ago EQS-Adhoc: Biotest AG: Increase of the EBIT guidance
PRESS RELEASE published on 10/05/2023 at 16:42, 2 years 3 months ago EQS-Adhoc: Biotest AG: Peter Janssen appointed new Chairman of the Board of Biotest AG
PRESS RELEASE published on 09/21/2023 at 09:00, 2 years 4 months ago Biotest AG: Biotest receives approval for innovative immunoglobulin Yimmugo® in the UK
PRESS RELEASE published on 09/12/2023 at 09:00, 2 years 4 months ago Biotest AG: Biotest treats first patient with severe community-acquired pneumonia in phase III trial with trimodulin
PRESS RELEASE published on 09/07/2023 at 09:00, 2 years 4 months ago Biotest AG: US Food and Drug Administration FDA accepts marketing authorization application for immunoglobulin Yimmugo
Published on 01/30/2026 at 14:00, 59 minutes ago CCL to Hold Live Webcast to Discuss Fourth Quarter and Year End 2025 Results, Thursday, February 26, 2026, at 7:30 a.m. ET
Published on 01/30/2026 at 08:35, 6 hours 24 minutes ago Alaska Energy Metals Announces Closing Of Life Offering of Units
Published on 01/30/2026 at 08:00, 6 hours 59 minutes ago Troubadour Resources Intercepts Target Mineralization Near Surface during Phase 1 of the Multi-Phase Drill Program at Senneville Gold-Silver-Copper Property
Published on 01/30/2026 at 02:15, 12 hours 44 minutes ago Canex Metals Announces Success of Gold Basin Take-Over Bid, Extension of the Partial Revocation of the Cease-Trade Order Imposed on Gold Basin, Waiver of All Remaining Conditions, Initiation of the Share Take Up Process, and Mandatory 10-Day Extension
Published on 01/30/2026 at 00:00, 14 hours 59 minutes ago LIR Life Sciences Reports Positive Interim Preclinical Results from Comparative Animal Study of Novel CPP-Enabled Transdermal Delivery of GLP/GIP-Based Therapies
Published on 01/30/2026 at 14:11, 48 minutes ago SBF AG expects stable to positive business development in a challenging environment for 2026
Published on 01/30/2026 at 13:30, 1 hour 29 minutes ago North Peak Expands Wabash Gold Mineralization at Prospect Mountain, Nevada
Published on 01/30/2026 at 12:00, 2 hours 59 minutes ago HSBC UK and Sage simplify tax reporting for small businesses ahead of Making Tax Digital
Published on 01/30/2026 at 11:54, 3 hours 5 minutes ago EQS-Adhoc: YOC AG: PRELIMINARY FIGURES FOR THE 2025 FINANCIAL YEAR
Published on 01/30/2026 at 10:30, 4 hours 29 minutes ago ASTA ENERGY SOLUTIONS AG SUCCESSFULLY COMPLETES IPO
Published on 01/29/2026 at 18:00, 20 hours 59 minutes ago GUILLEMOT CORPORATION: FULL-YEAR 2025 CONSOLIDATED TURNOVER UP 2%
Published on 01/29/2026 at 17:45, 21 hours 14 minutes ago LANSON-BCC ANNOUNCES 2025 REVENUES AND FINALISES THE ACQUISITION OF HEIDSIECK & C° MONOPOLE
Published on 01/29/2026 at 17:45, 21 hours 14 minutes ago Cegedim generated LFL revenue growth of 1.1% in 2025